Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review.

Katusiime, Christine; Ocama, Ponsiano; Kambugu, Andrew

Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review.

Files

Basis of selection of first and second line highly active antiretroviral therapy for hivaids.pdf (172.48 KB)

Date

2014

Authors

Katusiime, Christine

Ocama, Ponsiano

Kambugu, Andrew

Publisher

African Health Sciences

Abstract

The effectiveness of combination antiretroviral therapy (cART) continues to improve as treatment choices expand with the development of new antiretroviral agents and regimens. However, the successful long-term treatment of HIV/AIDS is under threat from the emergence of drug-resistant strains to multiple agents and entire drug classes.

Keywords

Genetic barrier, Highly active antiretroviral therapy, HIV resistance

Citation

Katusiime, C., Ocama, P., & Kambugu, A. (2014). Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review. African Health Sciences, 14(3), 679-681. http://dx.doi.org/10.4314/ahs.v14i3.25

URI

http://dx.doi.org/10.4314/ahs.v14i3.25
https://nru.uncst.go.ug/handle/123456789/3062

Collections

Medical and Health Sciences

Full item page